IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma
IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma
About this item
Full title
Author / Creator
SongTao, Qi , Lei, Yu , Si, Gui , YanQing, Ding , HuiXia, Han , XueLin, Zhang , LanXiao, Wu and Fei, Yao
Publisher
Oxford, UK: Blackwell Publishing Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Oxford, UK: Blackwell Publishing Ltd
Subjects
More information
Scope and Contents
Contents
Recent studies have shown that isocitrate dehydrogenase1/2 (IDH1/2) mutations occur frequently in secondary glioblastoma. This study aimed to investigate their impact on temozolomide chemosensitivity and relationship with O(6)‐methylguanine DNA methyltransferase (MGMT) promoter methylation in secondary glioblastoma. Searches for IDH1 and IDH2 mutat...
Alternative Titles
Full title
IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3159103398
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3159103398
Other Identifiers
ISSN
1347-9032
E-ISSN
1349-7006
DOI
10.1111/j.1349-7006.2011.02134.x
